Heart failure and diabetes: Pathogenesis and management

Research output: Contribution to journalArticle

Abstract

The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30% higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and comorbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.

Original languageEnglish
Pages (from-to)231-239
Number of pages9
JournalMinerva Medica
Volume97
Issue number3
StatePublished - Jun 2006

Fingerprint

Heart Failure
Left Ventricular Dysfunction
Myocardial Ischemia
Coronary Disease
Clinical Trials
Physicians
Mortality
Incidence
Therapeutics

Keywords

  • Diabetes
  • Heart failure, congestive, physiopathology
  • Heart failure, congestive, therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Heart failure and diabetes : Pathogenesis and management. / Kamalesh, Masoor.

In: Minerva Medica, Vol. 97, No. 3, 06.2006, p. 231-239.

Research output: Contribution to journalArticle

@article{7269beda0207457085964d48ae1cbe3a,
title = "Heart failure and diabetes: Pathogenesis and management",
abstract = "The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30{\%} higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and comorbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.",
keywords = "Diabetes, Heart failure, congestive, physiopathology, Heart failure, congestive, therapy",
author = "Masoor Kamalesh",
year = "2006",
month = "6",
language = "English",
volume = "97",
pages = "231--239",
journal = "Minerva Medicolegale",
issn = "0026-4806",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Heart failure and diabetes

T2 - Pathogenesis and management

AU - Kamalesh, Masoor

PY - 2006/6

Y1 - 2006/6

N2 - The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30% higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and comorbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.

AB - The incidence of diabetes among patients with congestive heart failure (CHF) is increasing. Despite advances in therapy for CHF, mortality remains about 30% higher for diabetics with CHF than non-diabetics. Multiple mechanisms are responsible for development of CHF in diabetes with ischemic heart disease and its attendant complication of left ventricular dysfunction playing a major role. The prevalence of diabetes is rising worldwide. Thus in the foreseeable future, it appears that physicians will have to deal with increasing numbers of subjects with diabetes, coronary disease and heart failure. Management of diabetes and comorbid conditions plays a vital role in the prevention of development CHF in subjects with diabetes. Treatment of asymptomatic left ventricular dysfunction and management of CHF has been evolving over last few years with major clinical trials advancing our knowledge. This review highlights some of the new developments in this field.

KW - Diabetes

KW - Heart failure, congestive, physiopathology

KW - Heart failure, congestive, therapy

UR - http://www.scopus.com/inward/record.url?scp=33749352995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749352995&partnerID=8YFLogxK

M3 - Article

C2 - 16855518

AN - SCOPUS:33749352995

VL - 97

SP - 231

EP - 239

JO - Minerva Medicolegale

JF - Minerva Medicolegale

SN - 0026-4806

IS - 3

ER -